[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BR0307893A - Formulação oftálmica com sistema de goma - Google Patents

Formulação oftálmica com sistema de goma

Info

Publication number
BR0307893A
BR0307893A BR0307893-0A BR0307893A BR0307893A BR 0307893 A BR0307893 A BR 0307893A BR 0307893 A BR0307893 A BR 0307893A BR 0307893 A BR0307893 A BR 0307893A
Authority
BR
Brazil
Prior art keywords
ophthalmic formulation
gum system
gum
eye
active agent
Prior art date
Application number
BR0307893-0A
Other languages
English (en)
Inventor
Satish K Singh
Paramita Bandyopadhyay
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0307893A publication Critical patent/BR0307893A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"FORMULAçãO OFTáLMICA COM SISTEMA DE GOMA". A presente invenção refere-se a uma composição farmacêutica adequada para a administração tópica a um olho, a composição compreendendo (a) uma concentração farmacologicamente eficaz de um agente ativo; e (b) um conjunto de pelo menos dois polímeros oftalmicamente compatíveis compreendendo um novo sistema de goma. Em modalidades preferidas da presente invenção, as composições aumentam o tempo de retenção do agente ativo no olho, quando em comparação com as composições com outras gomas ou sistemas de gomas.
BR0307893-0A 2002-02-22 2003-02-20 Formulação oftálmica com sistema de goma BR0307893A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35876102P 2002-02-22 2002-02-22
PCT/US2003/005361 WO2003072081A1 (en) 2002-02-22 2003-02-20 Ophthalmic formulation with gum system

Publications (1)

Publication Number Publication Date
BR0307893A true BR0307893A (pt) 2004-12-07

Family

ID=27765988

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307893-0A BR0307893A (pt) 2002-02-22 2003-02-20 Formulação oftálmica com sistema de goma

Country Status (10)

Country Link
US (1) US7128928B2 (pt)
EP (1) EP1476135A1 (pt)
JP (1) JP2005521690A (pt)
AR (1) AR038575A1 (pt)
AU (1) AU2003213210A1 (pt)
BR (1) BR0307893A (pt)
CA (1) CA2477044A1 (pt)
MX (1) MXPA04008171A (pt)
TW (1) TW200400055A (pt)
WO (1) WO2003072081A1 (pt)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20090215735A1 (en) * 2002-02-25 2009-08-27 Alcon, Inc. Topical solution formulations containing a corticosteroid and a cyclodextrin
US7914803B2 (en) * 2003-06-13 2011-03-29 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of three polymers
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
JP4860475B2 (ja) * 2003-06-13 2012-01-25 アルコン，インコーポレイテッド ２種のポリマーの相乗作用的組み合わせを含む眼科用組成物
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
EP1648407A4 (en) 2003-07-21 2011-08-31 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, CORRESPONDING USE AND FORMULATION
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2007502296A (ja) 2003-08-11 2007-02-08 アドバンシス ファーマスーティカル コーポレイション ロバストペレット
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
EP1658034A4 (en) 2003-08-29 2011-06-22 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
WO2005027877A1 (en) 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004305539B2 (en) * 2003-12-11 2010-09-02 Alcon, Inc. Ophthalmic compositions containing a polysaccharide/borate gelling system
US20070020299A1 (en) 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
DE602005015936D1 (de) * 2004-02-26 2009-09-24 Bausch & Lomb Viskoelastische alginat-zusammensetzung, herstellungsverfahren und verpackung
WO2005092387A1 (en) * 2004-03-10 2005-10-06 Shimoda Biotech (Pty) Ltd Stable injectable diclofenac compositions
KR20070004750A (ko) * 2004-03-25 2007-01-09 보오슈 앤드 롬 인코포레이팃드 건안증 치료에 있어서의 로테프레드놀　에타보네이트의용도
US20050215516A1 (en) * 2004-03-29 2005-09-29 Claudio Bucolo New free-radical scavenger containing viscoelastic composition, methods of use and package
AU2005269981A1 (en) 2004-07-02 2006-02-09 Bonck, John A Tablet for pulsed delivery
ATE452659T1 (de) * 2004-10-01 2010-01-15 Menicon Co Ltd Verfahren zur sterilisation verpackter kontaktlinsen mit verpackungslösung
US20060134060A1 (en) * 2004-12-22 2006-06-22 Erning Xia Ophthalmic compositions comprising Aloe Vera
DE602006010702D1 (de) 2005-06-29 2010-01-07 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
WO2007005421A2 (en) * 2005-07-01 2007-01-11 Bausch & Lomb Incorporated Long lasting alginate dry eye, related methods of manufacture and methods of use
CA2628570A1 (en) 2005-11-09 2007-05-18 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US20070110812A1 (en) * 2005-11-14 2007-05-17 Bausch & Lomb Incorporated Ophthalmic composition for dry eye therapy
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
WO2007087609A2 (en) * 2006-01-25 2007-08-02 Aciex, Inc. Formulations and methods for treating dry eye
EP2004203A4 (en) * 2006-03-28 2010-03-31 Javelin Pharmaceuticals Inc FORMULATIONS OF DICLOFENAC AND CYCLODEXTRIN BETA WITH LOW DOSAGE
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2008088612A1 (en) * 2006-12-20 2008-07-24 Bausch & Lomb Incorporated Method of stimulating the production of mucin in the eye of a patient
US7659259B2 (en) * 2006-12-21 2010-02-09 Bausch & Lomb Incorporated Method of treating inflammation of the eye
WO2008082948A2 (en) * 2006-12-29 2008-07-10 Bausch & Lomb Incorporated Ophthalmic alginate composition related methods of manufacture and methods of use
PL2109442T3 (pl) * 2007-02-09 2014-07-31 Novartis Ag Kompozycje oftalmiczne zawierające synergistyczną kombinację trzech polimerów
MX2009011801A (es) * 2007-05-04 2009-11-13 Baush & Lomb Inc Composiciones para reducir, aminorar, tratar o evitar afeccion de ojo seco y metodos para elaboracion y uso de las mismas.
KR20100016285A (ko) * 2007-05-07 2010-02-12 보오슈 앤드 롬 인코포레이팃드 안구건조 상태를 감소, 개선, 치료 또는 예방하기 위한 조성물 및 이의 제조 및 사용 방법
JP2010528014A (ja) * 2007-05-24 2010-08-19 アーシエックス セラピューティックス， インコーポレイテッド ドライアイを処置するための処方物および方法
ES2493641T3 (es) * 2007-06-28 2014-09-12 Cydex Pharmaceuticals, Inc. Administración nasal de soluciones acuosas de corticosteroides
US20110046033A1 (en) * 2008-01-31 2011-02-24 Jinzhong Zhang Multipurpose Lens Care Solution with Benefits to Corneal Epithelial Barrier Function
US9096819B2 (en) 2008-01-31 2015-08-04 Bausch & Lomb Incorporated Ophthalmic compositions with an amphoteric surfactant and an anionic biopolymer
US9481856B2 (en) * 2008-06-09 2016-11-01 Bausch & Lomb Incorporated Pharmaceutical formulations comprising stabilized polysaccharides and source of hydrogen peroxide
CN102065838A (zh) * 2008-06-12 2011-05-18 诺瓦提斯公司 用于眼前部持续递送的原位胶凝系统
US20110195927A1 (en) * 2008-09-15 2011-08-11 Compositions Comprising Polymers Having Aminio Sugar Unites And Methods Of Making And Using Same Compositions Comprising Polymers Having Amino Sugar Units and Methods of Making and Using Same
US20100087550A1 (en) 2008-10-06 2010-04-08 Zora Marlowe Formulations with a Tertiary Amine Oxide
WO2010118340A1 (en) * 2009-04-09 2010-10-14 University Of Medicine And Dentistry Of New Jersey Treatment of cutaneous hemangioma
PT2506831E (pt) * 2009-12-03 2014-01-08 Alcon Res Ltd Suspensões de nanopartículas contendo um polímero de carboxivinilo
US20130165419A1 (en) * 2011-12-21 2013-06-27 Insite Vision Incorporated Combination anti-inflammatory ophthalmic compositions
TW201336527A (zh) * 2012-02-10 2013-09-16 Alcon Res Ltd 具增強的穩定性之水性藥學組成物
JP6207291B2 (ja) * 2013-08-07 2017-10-04 大同化成工業株式会社 外用剤用組成物
US10959990B2 (en) * 2013-08-28 2021-03-30 Presbyopia Therapies, Inc Compositions and methods for the treatment of presbyopia
US10052313B2 (en) * 2013-08-28 2018-08-21 Presbyopia Therapies, LLC Compositions and methods for the treatment of presbyopia
US10350232B1 (en) 2013-11-04 2019-07-16 Peter D. Jaillet Medicinal drops
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents
WO2017074965A1 (en) * 2015-10-25 2017-05-04 Iview Therapeutics, Inc. Pharmaceutical formulations that form gel in situ
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
US11648247B1 (en) 2021-12-16 2023-05-16 Lenz Therapeutics, Inc. Compositions and methods for the treatment of presbyopia

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
SE8305864D0 (sv) * 1983-10-25 1983-10-25 L E Medical Ogondroppar
DE3346123A1 (de) 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
US4727064A (en) 1984-04-25 1988-02-23 The United States Of America As Represented By The Department Of Health And Human Services Pharmaceutical preparations containing cyclodextrin derivatives
JPH0679545B2 (ja) 1985-03-08 1994-10-12 味の素株式会社 コンニヤクマンナン含有可逆性ゲル
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3704907A1 (de) 1987-02-17 1988-08-25 Bayer Ag Topisch anwendbare zubereitungen von gyrase-inhibitoren in kombination mit kortikosteroiden
NZ226171A (en) 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5135920A (en) 1988-11-16 1992-08-04 Takeda Chemical Industries, Ltd. Angiostatic agents
US5521222A (en) 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5369095A (en) 1990-02-14 1994-11-29 Alcon Laboratories, Inc. Compositions and method comprising substituted glycosides as mucus membrane permeation enhancers
US5227372A (en) 1990-03-07 1993-07-13 Children's Medical Center Corporation Method for retaining ophthalmological agents in ocular tissues
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5318780A (en) * 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
IL105553A (en) 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
NO304832B1 (no) 1992-05-27 1999-02-22 Ube Industries Aminokinolonderivater samt middel mot HIV
US5358706A (en) 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
JPH06345653A (ja) 1993-06-08 1994-12-20 Asahi Chem Ind Co Ltd 点眼液
US5631004A (en) 1993-09-30 1997-05-20 Alcon Laboratories, Inc. Use of sustained release antibiotic compositions in ophthalmic surgical procedures
SE9401108D0 (sv) 1994-03-31 1994-03-31 Leiras Oy Ophthalmic composition I
SE9401109D0 (sv) 1994-03-31 1994-03-31 Leiras Oy Opthalmic composition II
IL114193A (en) 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
TW434023B (en) 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
WO1997028827A1 (fr) 1996-02-07 1997-08-14 Rohto Pharmaceutical Co., Ltd. Composition ophtalmique possedant une viscosite adaptee
ES2298198T3 (es) 1996-04-11 2008-05-16 PHARMACIA & UPJOHN COMPANY LLC Procedimiento para preparar oxazolidinonas.
AU713062B2 (en) 1996-06-17 1999-11-25 Janssen Pharmaceutica N.V. Biconvex rapidly disintegrating dosage forms
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
GB9707934D0 (en) 1997-04-18 1997-06-04 Danbiosyst Uk Improved delivery of drugs to mucosal surfaces
US6046177A (en) 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US5874418A (en) 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
AU750207B2 (en) 1997-06-13 2002-07-11 Cydex Pharmaceuticals, Inc. Polar drug or prodrug compositions with extended shelf-life storage and a method of making thereof
GB9714102D0 (en) 1997-07-04 1997-09-10 Ciba Geigy Ag Compounds
ES2302881T3 (es) * 1997-07-29 2008-08-01 Alcon Laboratories, Inc. Composiciones oftalmicas que contienen polimeros de galactomanana y borato.
CN100387581C (zh) 1997-11-07 2008-05-14 法玛西雅厄普约翰美国公司 制备唑烷酮的方法
AU2798299A (en) 1998-02-27 1999-09-15 Althexis Company, The Therapeutic and prophylactic uses of negatively charged substituted disaccharides
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6552024B1 (en) 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
CZ200235A3 (cs) 1999-07-06 2002-05-15 The Procter & Gamble Company Předpřipravená gelová maska
WO2001019366A1 (en) 1999-09-13 2001-03-22 Insite Vision Incorporated Topical treatment for prevention of ocular infections
GB2363386B (en) 2000-06-16 2004-07-28 Chesham Chemicals Ltd Fluid gel comprising xanthan and non-gelling polysaccharides
AR031135A1 (es) * 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares

Also Published As

Publication number Publication date
WO2003072081A1 (en) 2003-09-04
US20030232089A1 (en) 2003-12-18
TW200400055A (en) 2004-01-01
JP2005521690A (ja) 2005-07-21
US7128928B2 (en) 2006-10-31
AU2003213210A1 (en) 2003-09-09
CA2477044A1 (en) 2003-09-04
EP1476135A1 (en) 2004-11-17
MXPA04008171A (es) 2004-11-26
AR038575A1 (es) 2005-01-19

Similar Documents

Publication Publication Date Title
BR0307893A (pt) Formulação oftálmica com sistema de goma
BR0212475A (pt) Composições farmacêuticas
BR0111126A (pt) Derivados de aminoácidos cìclicos úteis como agentes farmacêuticos
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
PT1061900E (pt) Composicoes e metodos para libertacao de uma droga
BR0108173A (pt) Composições farmacêuticas de toxina de botulina
BR122012030846B8 (pt) composição farmacêutica não aquosa para uso dermatológico compreendendo calcipotriol e pelo menos um corticoesteróide, e, uso da mesma
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
BR9810320A (pt) Composição farmacêutica sólida, contendo derivados de benzofurano
BR0008059A (pt) Composições de valdecoxib
BR0210139A (pt) Composições farmacêuticas
MXPA05001061A (es) Composiciones farmaceuticas, acuosas de 2,6-diisopropilfenol.
BR0116186A (pt) Sistema de gelificação reversìvel para liberação de droga ocular
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
FR2718963B1 (fr) Nouvelle composition pharmaceutique à base de taxoïdes.
BR0015256A (pt) Composições farmacêuticas contendo uma droga de antibiótico de fluoroquinolona e uma goma de xantano
SE9300581D0 (sv) Komposition foer nasalbehandling
RS50768B (sr) Režim doziranja i farmaceutska formulacija za urgentnu zaštitu
BR0313428A (pt) Composições farmacêuticas de drogas semi-ordenados e polìmeros
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
BR0308710A (pt) conjugados poliméricos antimicrobianos
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
BRPI0611526A2 (pt) composição tópica contendo gelatina

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A. E 7A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.